Skip to main content

New medicines advice for NHS Wales

Welsh Government has approved advice from the All Wales Medicines Strategy Group (AWMSG) for two new medicines.

  • Zanamivir (Dectova®) was recommended to treat severe flu (influenza virus infection). Dectova® is an antiviral medicine and is used when other flu treatments are not suitable. Adults and children aged six months or more can be treated with Dectova®.
  • Glecaprevir/pibrentasvir (Maviret®) was recommended to treat adolescents (12 to less than 18 years old) with long‑term (‘chronic’) hepatitis C. Maviret® is an antiviral medicine.  

AWTTC’s Patient Access to Medicines Service (PAMS) supports the AWMSG to assess and monitor new medicines in Wales.